Posters

Skin Research Group of Canada

SRGC Toronto 2022

Nov 24-26 | 9th Annual Conference
Clinical Skin Research

CSR22-01

The Efficacy of Off-label Use of Omalizumab for Solar Urticaria: A Systematic Review.

Jeffrey Toy, Faculty of Medicine, University of British Columbia

CSR22-02

Pityriasis Lichenoides Following SARS-CoV-2 Infection/ Vaccination.

Aileen Feschuk, Memorial University of Newfoundland

CSR22-03

Allogeneic neonatal skin fibroblasts do not trigger acute immune reactions compared to allogeneic adult skin fibroblasts.

Brice Magne, Centre de Recherche en Organogénèse Expérimentale de l'Université Laval/LOEX

CSR22-04

Patch testing delivery: a cross-sectional inquiry into the experiences of patch testing dermatologists.

Aysha Lukmanji, University of Calgary

CSR22-05

Complications of Body Piercings: A Systematic Review.

Santina Conte, Faculty of Medicine and Health Sciences, McGill University

CSR22-06

Clinical Features and Treatment of Sebaceous Carcinoma: A Systematic Review.

Thomas Sabljic, Department of Laboratory Medicine and Pathobiology, University of Toronto

CSR22-07

Cognitive Behavioral Therapy in Primary Dermatologic Disorders: A Scoping Review.

Dong Goo Lee, Faculty of Medicine, University of British Columbia

CSR22-08

Chilblain-like Lesions (CLL) Coinciding with the SARS-CoV-2 Pandemic: A Systematic Review.

Samantha Starkey, Faculty of Medicine, University of British Columbia

CSR22-09

Photography and Image Acquisition in Dermatology: A Scoping Review.

Nadia Kashetsky, Faculty of Medicine, Memorial University of Newfoundland

Kristie Mar, Faculty of Medicine, University of British Columbia

CSR22-10

Efficacy of N-acetylcysteine (NAC) in Trichotillomania (Hair-Pulling Disorder), Skin-Picking Disorder and Onychophagia (Compulsive Nail-Biting): A Systematic Review.

Nadia Kashetsky, Faculty of Medicine, Memorial University of Newfoundland

withdrawn

CSR22-11

Infantile Hemangiomas Involving the Ear and Periauricular Area: A Retrospective Study of Patients Referred to a Tertiary Clinic.

Maxine Joly-Chevrier, Faculty of Medicine, Université de Montréal

Education

EDU22-01

Learning practical dermatology skills through animated vignettes: An effective medical school educational intervention to support the dissemination of national guidelines.

Harry Chaocheng Liu, University of British Columbia

Wound Healing Fibrosis Regeneration

WHRG22-01

Epidemiology of Severely Burned Patients Requiring Autologous Skin Substitutes.

Ludivine DUBOURGET, LOEX, Centre de recherche du CHU de Québec-Université Laval

WHRG22-02

Compassionate use of allogeneic self-assembled skin substitutes for recessive dystrophic epidermolysis bullosa wound closure.

Martin Barbier, LOEX, CHU de Québec

WHRG22-03

Wound Healing: Exploring mechanisms whereby a new drug Ag373K augments VEGFA secretion and keratinocyte migration.

Vida Maksimoska, University of Toronto, Institute of Medical Sciences and St Micheals Hospital

Inflammatory Skin Diseases

INFSD22-01

The endocannabinoid system of psoriatic tissue-engineered skin models.

Andrea Tremblay, Université Laval

INFSD22-02

In vitro modeling by tissue engineering of the impact of sensory innervation in psoriasis.

Rémy Pépin, Faculty of Medicine, Université Laval

INFSD22-03

Health-related quality of life (HRQL) in a Canadian atopic dermatitis (AD) cohort.

Alexandra Yacovelli, McGill University Health Centre, Faculty of Medicine & Health Sciences, McGill University

Skin Cancer

SC22-01

Skin colour and perceptions of sun exposure among residents of Atlantic Canada: A preliminary analysis.

Sauliha Alli, Temerty Faculty of Medicine, University of Toronto

SC22-02

Investigating the evolution of sun protection habits of the Canadian population living in the Atlantic provinces.

Jonathan Lebeau, Division of Experimental Medicine, Department of Medicine, Faculty of Medicine and Health Sciences, McGill University

SC22-03

Skin Surveillance After A Previous Cutaneous Melanoma Diagnosis: A Scoping Review.

Leah Johnston, University of Calgary

SC22-04

Role of soluble CD109 in Squamous Cell Carcinoma (SCC) progression.

Varsha Reddy Durgempudi, McGill University

SC22-05

Transitioning to pegylated interferon for the treatment of Cutaneous T-cell lymphoma: Meeting the challenge of therapy discontinuation and a proposed algorithm.

Selena Osman, University of Calgary

SC22-06

Evaluating the Impact of BRAF Reflex Mutation Testing on the Management of Melanoma, Lung, and Colorectal Cancers in Canada.

Sera Whitelaw, Faculty of Medicine and Health Sciences, McGill University

SC22-07

Skin cancer risk factors, sun safety behaviours and melanoma concern in Atlantic Canada: a comprehensive survey study.

Francois Lagace, Division of Dermatology, Faculty of Medicine, McGill University

SC22-08

Translational Landscape of High-Risk Basal Cell Carcinoma.

Misha Fotovati, Faculty of Medicine, McGill University

SC22-09

The Evolving Trends of Artificial Intelligence Skin Cancer Articles Published in Dermatology Journals.

Maxine Joly-Chevrier, Faculty of Medicine, Université de Montréal

SC22-10

Comparison of Basal Cell Carcinoma Posts, Comments and Authors Between Reddit and Quora Forums.

Maxine Joly-Chevrier, Faculty of Medicine, Université de Montréal

SC22-11

Melanoma Survival in Canada: A national population-based study elucidating healthcare and socioeconomic barriers affecting patient care.

Santina Conte, Faculty of Medicine and Health Sciences, McGill University

SC22-12

Gene-environment analyses in a UK Biobank cohort of four skin cancers identify synergistic contributions of DNA- and environment-based factors.

Richie Jeremian, Faculty of Medicine & Health Sciences, McGill University

SC22-13

Evaluating the expression and function of meiCT gene, Disrupted Meiotic cDNA1 in Head and Neck squamous cell carcinoma.

Raman Preet Kaur Gill, McGill University

Basic Sciences

BS22-01

Characterization and functional relevance of microfibrillar-associated protein 4 (MFAP4) in elastic fiber formation.

Dieter Reinhardt, McGill University

BS22-02

Efficient generation of induced pluripotent stem cell derived mesenchymal stem cells from a non-invasive, accessible tissue source - the plucked hair follicle.

Amatullah Fatehi, Acorn Biolabs and University of Toronto

End of list
Poster set up

THURSDAY, 24 NOVEMBER

7:30 - 8:00 AM EDT

(Please refer to your poster ID on the poster board for set up) 

Poster size
printed

4ft X 4ft

Poster sessions

THURSDAY, 24 NOVEMBER

10:00 - 12:00 PM EDT

Come See My Poster (Moderated Poster Walks)

AND

FRIDAY, 25 NOVEMBER

10:00 - 12:00 PM EDT

Come See My Poster

Poster Evaluation

THURSDAY, 24 NOVEMBER

10:00 - 12:00 PM EDT

Poster Takedown

SATURDAY, 26 NOVEMBER

10:00 - 10:30 AM EDT